Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Use of bisaramil in oxidative stress-related conditions

Sep. 20, 1996

Valaciclovir for restenosis

Sep. 20, 1996

Zambon's ACE/NEP inhibitors for cardiovascular indications

Sep. 20, 1996

Schering AG investigates LTB4 inhibitors

Sep. 20, 1996

5-LO inhibitor from Bristol-Myers Squibb

Sep. 20, 1996

Anti-IL-8 antibodies claimed by Genentech

Sep. 20, 1996

Metabotropic glutamate antagonists from Novo Nordisk

Sep. 20, 1996

Bayer patents new compounds for CNS disorders

Sep. 20, 1996

Hoechst Marion Roussel reports new antidepressants

Sep. 20, 1996

New CNS agents from American Cyanamid

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...